Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Definity-enhanced vs unenhanced echocardiography for LVEF accuracy
NCT00401687Phase 4Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Jul 2006
- Primary completion
- Jun 2007
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of perflutren lipid microspheres, sponsored by Lantheus Holdings, Inc. Primary endpoint: Accuracy of Left Ventricular Ejection Fraction. Started Jul 2006; status: completed.
02
Drugs
perflutren lipid microspheres
Beyond the preview
Go deeper on NCT00401687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401687.